TrialClinIQ uses an AI-powered platform to optimize patient matching for CNS clinical trials, reducing screening failures and accelerating enrollment. The platform analyzes complex neurological data and provides specialized dashboards for CNS endpoints, connecting patients to relevant therapies faster.
Funding
Funding not disclosed
Founders
Product
Problem
Recruiting participants for Central Nervous System (CNS) clinical trials is often hindered by significant geographic and informational barriers. This results in prolonged enrollment timelines and delayed access to potentially life-changing therapies for patients with neurological conditions.
Solution
TrialClinIQ offers an AI-powered platform designed to optimize patient matching for CNS clinical trials. Our proprietary algorithms analyze complex neurological data to identify suitable candidates with increased precision, thereby reducing screening failures. The platform breaks down traditional recruitment obstacles, facilitating faster connections between patients and relevant CNS therapies. We provide specialized dashboards that aggregate and visualize critical CNS endpoints, including cognitive assessments, biomarkers, and neuroimaging data. This focused approach accelerates the enrollment process and supports the advancement of neurological research.
Target Audience
Our primary customers are pharmaceutical companies, contract research organizations (CROs), and academic research institutions conducting CNS clinical trials.
Features
- AI-driven patient matching engine trained on neurological condition data to enhance trial recruitment accuracy.
- Reduction in screening failures by up to 65% through precise patient-protocol alignment.
- Specialized dashboards for visualizing and analyzing CNS-specific endpoints such as cognitive assessments, biomarkers, and neuroimaging.
- Capability to process and analyze complex neurological data, including brain imaging and genetic markers.
- FDA-validated platform adhering to specialized CNS regulatory pathways and endpoint validation standards.
- Digital tools tailored for CNS patients, including simplified participation interfaces and cognitive assessment modules.
- HIPAA-compliant infrastructure ensuring data privacy and security.